US Pharmaceutical/Medical Device Regulatory and Product Development Overview Tom Gardner.

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

David M. Pollock Medical College of Georgia Discovery-Academia.
Ferring Controlled Therapeutics
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
Key Questions WHO WHAT WHERE WHEN WHY HOW Pfizer Inc
The AsthmaCo. June $8.9B Problem in Asthma SALBUTAMOL (a.k.a. Albuterol) is the ONLY short-acting bronchodilator – several “me toos” - all act via.
Quality by Design: A Challenge to the Pharma Industry CAMP Member Companies March 2002 CAMP.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Translational Medicine Turning Basic Research into Medicines and Treatments.
Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan.
Nanotechnology in Drug Discovery- Development and Delivery
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 13 Technology in Medicine.
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
National University of Singapore Department of Pharmacy 21 Nov 2006 KPP Prasad, Ph.D. Quality Operations Director Pfizer Global Manufacturing The Pharmaceutical.
Regulatory Issues. Introduction to the Regulatory Approval Process; Overview of the FDA Investigational New Drug Application (IND); Summary of regulations.
1 1 PDUFA & FDA Legislation FDA Regulatory & Compliance Symposium August 2006 Marc Wilenzick, Moderator for Panel: Dan Carpenter, Harvard Dept. of Government.
1 Global New Employee Orientation Workshop Welcome.
© Peter-Jan Engelen Handling Complex Decisions in the Development of New Drugs in Pharmaceutical Firms FUR XII, LUISS, Roma, Italy, June 2006 Cassimon,
Stages of drug development
Regulatory Overview.
Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Obtaining and Negotiatiing a Position in Industry/Biotech Roy G. Smith Ph.D. Director, Huffington Center on Aging Professor, Department of Molecular and.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Chapter 1.3.  Sell 1 group of similar products.  Ex. The protocols for manufacturing recombinant human growth hormone are almost identical to those.
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Stefan Franzén Introduction to clinical trials.
INTRODUCTION TO RA.
Validation is Always Part of the Picture Ongoing Validation (DOE, IQ, OQ, PQ, PV)* Pre-INDPhase IPhase IIPhase III Commercial Manufacturing * DOE = Design.
3rd Dimension of Product Translation: Industrialization
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
FDA Focus On Consumer Protection
THE BIOTECHNOLOGY WORKPLACE. OVERVIEW Biotechnology workplaces Laboratories.
1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.
HSC 6636: Pharmaceuticals & Medical Technology 1 Dr. Lawrence West, Health Management and Informatics Department, University of Central Florida
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
FDA Health Psychology. FDA = Food & Drug Administration Part of Dept of Health & __________ Services.
FDA Office of Orphan Products Development
1 Operation of the Prescription Drug User Fee Program Janet Woodcock, M.D. Deputy Commissioner for Operations November 14, 2005.
Experiences (and frustrations) in Developing a Biotech Company in Idaho.
GenCo Sam Rana 12/16/13.
CTEP Visiting Physician Externship Coordinator: Igor Espinoza-Delgado, M.D. NCI CTEP Investigational Drug Branch
ARRRR! Drug Development and Discovery Access to Essential Medicines De-Cal Fall Week 2.
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
Figure 1.1. Industry Value Chain Problem to be solved Technology innovation Basic research Applied research Pilot phase (Prod dev) Application phase (Production)
Progression of New Drug: From Idea to Public Consumption Chris DeFarlo Writing in the HLTH Professions Unit 2 Prof. Edwards.
1 Destination India: Contract Research in Pharmaceuticals & Healthcare S.P. Vasireddi, Ph.D Chairman, ACRO 26/03/2009.
Presentation by Dr. Andreas O. Tobler September 1, 2011 Tento projekt je spolufinancován Evropským sociálním fondem a státním rozpočtem České republiky.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.
© Coherent market Insights. All Rights Reserved PEDIATRIC CLINICAL TRIALS MARKET Global Industry Insights, Outlook Size, Share and Opportunity Analysis,
© Coherent market Insights. All Rights Reserved BIOSIMILAR PIPELINE ANALYSIS MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis,
Drug Development Process Stages involved in Regulating Drugs
Contract Research organizations
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
2000 NMT was founded by Prof. Jimmy Yun & Prof. Chen Jianfeng
Clinical Trials — A Closer Look
Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024
PREFORMULATION Important stages where Preformulation, Biopharmaceutics and Formulation plays a key role are – Candidate drug selection Various stages of.
The Lifecycle of Pharmaceutical products
Gestora brasileiro focada exclusivamente na área da saúde.
9.4 Product Quality Control
Bio-Facility Qualification, Start-Up & Licensure
PAI Preparation and Readiness
A Real World Application of the Scientific Method
Pharmaceuticals Industry
Presentation transcript:

US Pharmaceutical/Medical Device Regulatory and Product Development Overview Tom Gardner

Product Development  Pharmaceuticals  Medical Devices  Bio-Technology  Equipment  Support Products  Pharmaceuticals  Medical Devices  Bio-Technology  Equipment  Support Products

Who Am I:  20+ years in pharmaceutical industry  Quality Analyst, Manufacturing Management, R&D Product Development, Clinical Supplies, Senior Scientist and Product and Process Development Coordinator  Involved in 7 approved FDA product/device filings and over 50 product development projects  20+ years in pharmaceutical industry  Quality Analyst, Manufacturing Management, R&D Product Development, Clinical Supplies, Senior Scientist and Product and Process Development Coordinator  Involved in 7 approved FDA product/device filings and over 50 product development projects

Overview of Typical Pharmaceutical Product Development 4 PreClinical Work Clinical Studies Registration Validation Commercial Production FILINGFILING APPROVALAPPROVAL VALIDATIONVALIDATION IP Marketing Research Marketing Plan 1 In 2000 Dollars - Estimates by the National Cancer Institute for all new pharmaceutical. Estimate does not consider R&D costs that are not associated with the development of the drug in question. Most drug companies use a system of cost estimates that includes the valuation of money if it had been invested andthe cost of drug development not approved by the FDA. Most studies conclude that the rate of commercialization success to be 1:5000. How Much does it cost to develop a new drug - James Love Consumer Project on Technology April 2, 2000http:// 2 Drug Approval Overregulation, MR Ward - CATO Regulation New York Times - November Cost: 1 Preclinical to Phase II - Approximately 1-7 million Phase III million Time: 2,3 Validation Batches - Product Costs and Labor X 3 to 5 batches Production Start Up Costs based on Contract or Facility Total Costs = million USD Preclinical to Completed Clinicals years FDA Approval months 3 Validation and Production Launch months Total Time = years Product Launch

Welcome to the Jungle 5 Pre Clinical Work Clinical Trials Registration Validation Registration Validation Commercial Production Commercial Production Filing Approval Pre Approval Inspection Stability Stable Unstable FAIL GO Animal Effective Ineffective FAIL GO Toxicology Safe Toxic FAIL GO Micro Antimicrobial & Aseptic Grows Bugs FAIL GO Chemistry Passes ID & Description Degradants & Impurities FAIL GO Reformulation Egg START OVER Reformulation Egg START OVER REFORMULATE Death of Product Phase I Phase I Proof of Concept Phase II Phase II Efficacy Phase III Phase III Definition FAIL Ineffective Effective GO FAIL Ineffective Inferior Effective GO Tweak Formula Re-Evaluate FAIL Ineffective Effective GO Clinical Report Failure is Unlikely Min. Energy Batch Max. Energy Batch Nominal Batch Nominal Batch FAIL GO FAIL GO PASS GO PASS Reset Parameters Reset Parameters RESET ALL PARAMETERS Quarantine Product Scale Up Production Scale Up Production Launch Ad Campaign Launch Ad Campaign Fill Sales & Warehouse Pipeline Fill Sales & Warehouse Pipeline Launch Validation Report Stability Testing Sell Product Validation Sign Off Phase IV Phase IV FDA STUDIES Formula Improvement Geriatric or Pediatric Drug Interaction Define LT & Side Effects

Is it worth the trouble?